How would you measure the success of Cue Health's COVID-19 test cartridges?

Introduction

Measuring the success of Cue Health's COVID-19 test cartridges requires a comprehensive approach that considers multiple stakeholders and metrics. To address this product success metrics challenge, I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Cue Health's COVID-19 test cartridges are a critical component of their at-home diagnostic system. These single-use cartridges work in conjunction with the Cue Reader device to provide rapid, lab-quality COVID-19 test results.

Key stakeholders include:

• End-users (consumers and healthcare professionals)
• Healthcare providers and institutions
• Regulatory bodies (FDA, CDC)
• Cue Health's management and shareholders

User flow:

1. User inserts cartridge into Cue Reader
2. User collects nasal sample using provided swab
3. Sample is inserted into cartridge
4. Reader processes sample and delivers results via mobile app

The product fits into Cue Health's broader strategy of democratizing healthcare through accessible, accurate diagnostics. It competes with other at-home COVID-19 tests, distinguishing itself through its molecular testing approach and connectivity features.

Product Lifecycle Stage: Growth - The product has gained traction but still has significant room for expansion and improvement.

Hardware considerations:

• Manufacturing scalability
• Quality control in production
• Integration with Cue Reader device
• Shelf-life and storage requirements

Physical Product aspects:

• Distribution through healthcare channels and direct-to-consumer
• Inventory management and expiration dates
• Packaging for safe transport and storage